Stefan Kasper-Virchow

Stefan Kasper-Virchow

Switzerland SwitzerlandoncologistMale9.0Global Dominance: 0.00%

Stefan Kasper-Virchow is an oncologist at the University Hospital Essen in Germany, known for his contributions to cancer research and treatment. He recently gained attention for his involvement in the groundbreaking announcement of a new cancer drug, Daraxonrasib, which has shown significant promise in improving survival rates for patients with pancreatic cancer.

Power618
Reach7,645

Country presence

Recent news mentions

Stefan Kasper-Virchow is an oncologist from the University Hospital Essen who attended the ASCO Congress and described the atmosphere during the presentation of the new drug.

Durchbruch mit neuem Medikament Daraxonrasib
Neue Zürcher Zeitung·SwitzerlandSwitzerland· 2026-07-21
9.0